Hotel Riu Plaza Berlin
Martin-Luther-Straße 1, 10777
This premier B2B event provides the appropriate platform to engage and discuss ideas with your peers, while facilitating a professional atmosphere and environment for good company representation and development.
The Summit will shed light on current challenges, best practice and the inside view of the future of Precision Medicine.
We will discuss key findings, including critical insights, as well as recommendations for driving efficient strategies in the Precision Medicine Public Health landscape.
Key Practical Learning Points of the Summit:
Who Should Attend:
Chief Executives, Directors, Vice Presidents, Department Heads, Leaders and Managers specialising in:
From Industries Including:
Andrew Fried MBA Life Sciences Europe Director IBM, UK
Dr. Arndt Schmitz Research Biobank & Senior Translational Assay Technology Expert Bayer Pharma AG, Germany
Dr. François-Pierre Martin Senior Project Leader and Senior PI, Nutrition and Metabolic Health Nestlé Institute of Health Sciences SA, Switzerland
Dr. Jonathan Sheldon Global VP, Healthcare Health Sciences Global Business Unit Oracle, UK
Dr. Josef Straub Associated Director Clinical Biomarkers & Companion Diagnostics R&D, Global Early Development Merck KGaA, Germany
Dr. Oliver Chao Head, Emerging Biomedical Sciences Strategy & Innovation Sanofi, France
Please, complete details below:
Please, complete details below and you will get Agenda via E-mail:
Please, complete details below and you will get 500 € Document Package: